Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the Price/OCF ratio high or low?
The Price/OCF ratio of 349.89 is in line with its estimated 1-year average of 359.32, near the low end of its estimated 1-year range (321.95–432.79).
As of 2026-10-06T21:38:30.187Z.
Calculation as of: 2026-10-06T21:38:30.187Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2f5c47113f9c506e2e082fd2a1fe30760bd520268ada69101bb9e18573fa4dd9
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/OCF RATIO
349.89
PRICE/OCF RATIO AVG TTM
N/A
PRICE/OCF RATIO AVG 3Y
N/A
PRICE/OCF RATIO AVG 5Y
N/A
PRICE/OCF RATIO AVG 10Y
N/A
PRICE/OCF RATIO AVG 15Y
N/A
PRICE/OCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
17.13
median of 235 covered companies
CURRENT VS SECTOR MEDIAN
+1942.56%
vs the sector median at left
Market Cap
$870.81M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$857.16M
Price/OCF Ratio
N/A
TTM Avg
57.31
3Y Avg
41.26
5Y Avg
28.10
Market Cap
$853.13M
Price/OCF Ratio
10.75
TTM Avg
9.59
3Y Avg
13.93
5Y Avg
222.48
Market Cap
$884.97M
Price/OCF Ratio
N/A
TTM Avg
1973.56
3Y Avg
1192.17
5Y Avg
1192.17
Market Cap
$887.99M
Price/OCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | PRICE/OCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SI-BONE, Inc. (SIBN) | $867.03M | 349.89 | N/A | N/A | N/A |
| Odyssey Therapeutics, Inc. (ODTX)vs › | $870.81M | N/A | N/A | N/A | N/A |
| QuidelOrtho Corporation (QDEL)vs › | $857.16M | N/A | 57.31 | 41.26 | 28.10 |
| Alumis Inc. (ALMS)vs › | $855.38M | N/A | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $853.13M | 10.75 | 9.59 | 13.93 | 222.48 |
| SL Science Holding Ltd (SLBT)vs › | $852.35M | N/A | N/A | N/A | N/A |
| Arbutus Biopharma Corp (ABUS)vs › | $884.97M | N/A | 1973.56 | 1192.17 | 1192.17 |
| Bioventus Inc. (BVS)vs › | $887.50M | 9.16 | 9.21 | 23.47 | 25.52 |
| Corvus Pharmaceuticals, Inc. (CRVS)vs › | $887.99M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $838.62M | N/A | 185.06 | 185.06 | 185.06 |
P/OCF Ratio
349.9
P/FCF Ratio
N/A
P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PRICE/OCF RATIO |
|---|---|
| 2026-10-05 | 353.53 |
| 2026-10-02 | 322.66 |
| 2026-10-01 | 328.55 |
| 2026-09-30 | 335.51 |
| 2026-09-29 | 341.76 |
| 2026-09-28 | 334.80 |
| 2026-09-25 | 331.76 |
| 2026-09-24 | 330.51 |
| 2026-09-23 | 331.94 |
| 2026-09-22 | 335.69 |
| 2026-09-21 | 329.26 |
| 2026-09-18 | 322.84 |
| 2026-09-17 | 321.95 |
| 2026-09-16 | 330.87 |
| 2026-09-15 | 331.05 |
| 2026-09-14 | 333.72 |
| 2026-09-11 | 328.01 |
| 2026-09-10 | 326.59 |
| 2026-09-09 | 328.55 |
| 2026-09-08 | 332.30 |
| 2026-09-04 | 330.16 |
| 2026-09-03 | 332.65 |
| 2026-09-02 | 341.93 |
| 2026-09-01 | 337.65 |
| 2026-08-31 | 339.44 |
| 2026-08-28 | 342.83 |
| 2026-08-27 | 342.65 |
| 2026-08-26 | 346.75 |
| 2026-08-25 | 348.72 |
| 2026-08-24 | 347.47 |
| 2026-08-21 | 356.21 |
| 2026-08-20 | 347.64 |
| 2026-08-19 | 355.32 |
| 2026-08-18 | 341.58 |
| 2026-08-17 | 333.55 |
| 2026-08-14 | 337.83 |
| 2026-08-13 | 338.19 |
| 2026-08-12 | 339.08 |
| 2026-08-11 | 335.51 |
| 2026-08-10 | 336.22 |
| 2026-08-07 | 332.12 |
| 2026-08-06 | 323.73 |
| 2026-08-05 | 321.95 |
| 2026-08-04 | 432.56 |
| 2026-08-03 | 432.79 |
| 2026-07-31 | 416.61 |
| 2026-07-30 | 422.00 |
| 2026-07-29 | 432.56 |
| 2026-07-28 | 420.60 |
| 2026-07-27 | 399.95 |
| 2026-07-24 | 389.87 |
| 2026-07-23 | 386.35 |
| 2026-07-22 | 391.98 |
| 2026-07-21 | 399.72 |
| 2026-07-20 | 401.60 |
| 2026-07-17 | 407.70 |
| 2026-07-16 | 415.67 |
| 2026-07-15 | 404.65 |
| 2026-07-14 | 396.67 |
| 2026-07-13 | 418.72 |
| 2026-07-10 | 411.92 |
| 2026-07-09 | 408.63 |
| 2026-07-08 | 396.20 |
| 2026-07-07 | 405.82 |
| 2026-07-06 | 414.73 |
| 2026-07-02 | 401.36 |
| 2026-07-01 | 394.09 |
| 2026-06-30 | 382.83 |
| 2026-06-29 | 395.97 |
| 2026-06-26 | 406.52 |
| 2026-06-25 | 393.15 |
| 2026-06-24 | 383.30 |
| 2026-06-23 | 374.15 |
| 2026-06-22 | 371.10 |
| 2026-06-18 | 371.57 |
| 2026-06-17 | 356.79 |
| 2026-06-16 | 361.48 |
| 2026-06-15 | 354.68 |
| 2026-06-12 | 361.72 |
| 2026-06-11 | 355.15 |
| 2026-06-10 | 360.55 |
| 2026-06-09 | 364.30 |
| 2026-06-08 | 351.16 |
| 2026-06-05 | 354.68 |
| 2026-06-04 | 349.05 |
| 2026-06-03 | 326.53 |
| 2026-06-02 | 328.64 |
| 2026-06-01 | 325.36 |
| 2026-05-29 | 330.75 |
| 2026-05-28 | 338.03 |
| 2026-05-27 | 339.20 |
| 2026-05-26 | 344.12 |
| 2026-05-22 | 344.36 |
| 2026-05-21 | 347.41 |
| 2026-05-20 | 347.64 |
| 2026-05-19 | 348.11 |
| 2026-05-18 | 346.24 |
| 2026-05-15 | 332.16 |
| 2026-05-14 | 342.48 |
| 2026-05-13 | 332.16 |
| 2026-05-12 | 326.06 |
